Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ClpP (Caseinolytic mitochondrial matrix peptidase proteolytic subunit) is a highly conserved serine protease found in bacteria, mitochondria of eukaryotes, and some chloroplasts. In humans, it is encoded by the *CLPP* gene and plays a critical role in protein quality control by degrading misfolded or damaged proteins within the mitochondrial matrix. It functions as part of larger ATP-dependent proteolytic complexes such as ClpXP or ClpAP. In bacteria, it's critical for stress response, virulence regulation, cell cycle progression, and adaptation to environmental changes. In humans, mutations in *CLPP* are associated with Perrault syndrome type 3 (PRLTS3). It has emerged as an anti-cancer target because its activation can induce selective cancer cell death via disruption of mitochondrial function and bacterial ClpPs are targets for novel antibiotics.
Activation of ClpP induces cancer cell death via disruption of mitochondrial function; inhibition of bacterial ClpP disrupts bacterial pathogenicity.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Caseinolytic mitochondrial matrix peptidase proteolytic subunit (ClpP).